Environ Health Perspect:孕期较高的硒和锰水平保护婴儿免受未来高血压的影响

2021-06-26 Viho MedSci原创

母亲怀孕期间接触到较高水平的微量矿物质锰和硒的儿童,在童年时患高血压的风险较低。研究人员还发现,当母亲血液中的镉(一种有毒的重金属)水平较高时,锰与儿童血压有更强的反向关系。

高血压(BP)是血管疾病(CVD)的主要危险因素,包括心脏病、中风、肾衰竭和阿尔茨海默氏病。它也非常普遍;每年在全世界造成780万人死亡。英国石油公司从童年到成年都在追踪,儿童血压升高与成年期高血压和心血管疾病有关。因此,确定儿童高血压的可改变的危险因素可能为心血管疾病的原始预防铺平道路。高血压的定义为收缩压超过140毫米汞柱或舒张压超过90毫米汞柱。

近日在Environmental Health Perspectives杂志上约翰霍普金斯大学彭博公共卫生学院的研究人员领导的一项研究中,在母亲怀孕期间接触到较高水平的微量矿物质锰和硒的儿童,在童年时患高血压的风险较低。研究人员还发现,当母亲血液中的镉(一种有毒的重金属)水平较高时,锰与儿童血压有更强的反向关系--暗示锰降低血压的部分原因是对抗镉的血压升高效应。

硒(Se)和锰(Mn)是人体必需的微量元素一些研究表明Se和Mn可能对高血压和CVD有保护作用铅(Pb)、汞(Hg)和镉(Cd)是一种毒性很高的金属,即使在微量水平上也会对健康造成不利影响。Mn和Se具有抗氧化的特性,并存在于各种食物中,包括坚果和谷物、多叶蔬菜、鱼和贝类。

研究人员分析了波士顿地区近1200名在2002年至2013年期间分娩的妇女的血液样本中的有毒金属和微量元素的水平。他们发现,母亲血液中较高的Se或Mn水平与她们的孩子在3到15年后的门诊中较低的血压读数有关。

母血红细胞铅、汞、镉、硒、锰的Spearman相关矩阵

铅、汞、镉、硒和锰浓度与儿童收缩压百分位数的关系

母亲的硒水平和其后代在儿童时期的血压降低之间的联系。母亲的硒水平每增加一倍,儿童的收缩压就会平均降低6.23点。锰与血压有类似的关系,表现不明显,暴露量增加一倍,收缩压平均降低2.62点。

结果表明,母亲在怀孕期间饮食中的硒和锰的健康水平可能会保护她们的孩子免受高血压的影响,强调了子宫内的营养和环境暴露对孩子心血管健康的重要性。用于分析的数据集涵盖了来自波士顿出生队列研究的1194对母子。孩子们的血压读数是在3-15岁之间进行的。大多数母亲是黑人(61%)或西班牙裔(20%)。

Cd本身与儿童血压没有关系,但研究人员发现,当母体血液中的Cd含量较高时,Mn与儿童血压之间的反比关系明显更强。这一发现表明,Mn可以专门保护Cd的高血压促进作用,甚至可能掩盖正常人群中镉的高血压促进作用。人们通常认为接触Cd等重金属只发生在职业环境中,但事实上这些金属就在我们身边--例如,普通香烟的烟雾中就有Cd。他们将儿童的血压读数与他们母亲血液中的有毒金属和微量元素的水平进行了比较,测量了有毒金属Pb、Hg和Cd。

母体铅、汞、镉、硒、锰浓度与孕期吸烟儿童收缩压百分位数的线性回归模型

怀孕期间吸烟母亲所生子女的母亲锰和儿童收缩压百分位数的相关性

研究发现孕期接触香烟烟雾的儿童,与高锰暴露相比,同时接触低锰的儿童在儿童时期可能更容易出现更高的血压。在Cd含量较高的母亲中,Mn对儿童SBP的保护作用更强这强调了Mn与Cd的明显联系。对于怀孕期间吸烟的母亲来说,优化锰水平可能会保护他们的孩子免于患上高BP和未来的心血管疾病。

希望未来的研究证实能宫内Mn、Se与儿童血压及Mn、Cd对儿童收缩压的交互作用。并能了解到这些关联背后的分子和代谢途径,如何将这些发现转化为临床和公共卫生实践,预防儿童血压过高。

文章参考:Mingyu Zhang, Tiange Liu, Guoying Wang, Jessie P. Buckley, Eliseo Guallar, Xiumei Hong, Mei-Cheng Wang, Marsha Wills-Karp, Xiaobin Wang, Noel T. Mueller. In Utero Exposure to Heavy Metals and Trace Elements and Childhood Blood Pressure in a U.S. Urban, Low-Income, Minority Birth CohortEnvironmental Health Perspectives, 2021; 129 (6): 067005 DOI: 10.1289/EHP8325

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1878385, encodeId=312d18e838557, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Feb 10 08:48:09 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861444, encodeId=8ba81861444b3, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Sep 21 16:48:09 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729002, encodeId=5e111e2900237, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Dec 17 15:48:09 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524322, encodeId=d4251524322d7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621905, encodeId=82c21621905f7, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977222, encodeId=e9c49e722259, content=这个研究亮点采用了<a href='/topic/show?id=84a7e893169' target=_blank style='color:#2F92EE;'>#统计#</a>限制性立方样条回归分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78931, encryptionId=84a7e893169, topicName=统计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jun 27 09:21:14 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977173, encodeId=5a089e717352, content=<a href='/topic/show?id=9b3996e6940' target=_blank style='color:#2F92EE;'>#锰#</a><a href='/topic/show?id=001450815b3' target=_blank style='color:#2F92EE;'>#微量元素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96769, encryptionId=9b3996e6940, topicName=锰), TopicDto(id=50815, encryptionId=001450815b3, topicName=微量元素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Jun 26 23:37:15 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2022-02-10 anminleiryan
  2. [GetPortalCommentsPageByObjectIdResponse(id=1878385, encodeId=312d18e838557, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Feb 10 08:48:09 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861444, encodeId=8ba81861444b3, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Sep 21 16:48:09 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729002, encodeId=5e111e2900237, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Dec 17 15:48:09 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524322, encodeId=d4251524322d7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621905, encodeId=82c21621905f7, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977222, encodeId=e9c49e722259, content=这个研究亮点采用了<a href='/topic/show?id=84a7e893169' target=_blank style='color:#2F92EE;'>#统计#</a>限制性立方样条回归分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78931, encryptionId=84a7e893169, topicName=统计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jun 27 09:21:14 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977173, encodeId=5a089e717352, content=<a href='/topic/show?id=9b3996e6940' target=_blank style='color:#2F92EE;'>#锰#</a><a href='/topic/show?id=001450815b3' target=_blank style='color:#2F92EE;'>#微量元素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96769, encryptionId=9b3996e6940, topicName=锰), TopicDto(id=50815, encryptionId=001450815b3, topicName=微量元素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Jun 26 23:37:15 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-09-21 shizhenshan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1878385, encodeId=312d18e838557, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Feb 10 08:48:09 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861444, encodeId=8ba81861444b3, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Sep 21 16:48:09 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729002, encodeId=5e111e2900237, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Dec 17 15:48:09 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524322, encodeId=d4251524322d7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621905, encodeId=82c21621905f7, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977222, encodeId=e9c49e722259, content=这个研究亮点采用了<a href='/topic/show?id=84a7e893169' target=_blank style='color:#2F92EE;'>#统计#</a>限制性立方样条回归分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78931, encryptionId=84a7e893169, topicName=统计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jun 27 09:21:14 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977173, encodeId=5a089e717352, content=<a href='/topic/show?id=9b3996e6940' target=_blank style='color:#2F92EE;'>#锰#</a><a href='/topic/show?id=001450815b3' target=_blank style='color:#2F92EE;'>#微量元素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96769, encryptionId=9b3996e6940, topicName=锰), TopicDto(id=50815, encryptionId=001450815b3, topicName=微量元素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Jun 26 23:37:15 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-12-17 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1878385, encodeId=312d18e838557, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Feb 10 08:48:09 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861444, encodeId=8ba81861444b3, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Sep 21 16:48:09 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729002, encodeId=5e111e2900237, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Dec 17 15:48:09 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524322, encodeId=d4251524322d7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621905, encodeId=82c21621905f7, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977222, encodeId=e9c49e722259, content=这个研究亮点采用了<a href='/topic/show?id=84a7e893169' target=_blank style='color:#2F92EE;'>#统计#</a>限制性立方样条回归分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78931, encryptionId=84a7e893169, topicName=统计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jun 27 09:21:14 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977173, encodeId=5a089e717352, content=<a href='/topic/show?id=9b3996e6940' target=_blank style='color:#2F92EE;'>#锰#</a><a href='/topic/show?id=001450815b3' target=_blank style='color:#2F92EE;'>#微量元素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96769, encryptionId=9b3996e6940, topicName=锰), TopicDto(id=50815, encryptionId=001450815b3, topicName=微量元素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Jun 26 23:37:15 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-06-28 july_979
  5. [GetPortalCommentsPageByObjectIdResponse(id=1878385, encodeId=312d18e838557, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Feb 10 08:48:09 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861444, encodeId=8ba81861444b3, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Sep 21 16:48:09 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729002, encodeId=5e111e2900237, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Dec 17 15:48:09 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524322, encodeId=d4251524322d7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621905, encodeId=82c21621905f7, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977222, encodeId=e9c49e722259, content=这个研究亮点采用了<a href='/topic/show?id=84a7e893169' target=_blank style='color:#2F92EE;'>#统计#</a>限制性立方样条回归分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78931, encryptionId=84a7e893169, topicName=统计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jun 27 09:21:14 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977173, encodeId=5a089e717352, content=<a href='/topic/show?id=9b3996e6940' target=_blank style='color:#2F92EE;'>#锰#</a><a href='/topic/show?id=001450815b3' target=_blank style='color:#2F92EE;'>#微量元素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96769, encryptionId=9b3996e6940, topicName=锰), TopicDto(id=50815, encryptionId=001450815b3, topicName=微量元素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Jun 26 23:37:15 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1878385, encodeId=312d18e838557, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Feb 10 08:48:09 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861444, encodeId=8ba81861444b3, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Sep 21 16:48:09 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729002, encodeId=5e111e2900237, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Dec 17 15:48:09 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524322, encodeId=d4251524322d7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621905, encodeId=82c21621905f7, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977222, encodeId=e9c49e722259, content=这个研究亮点采用了<a href='/topic/show?id=84a7e893169' target=_blank style='color:#2F92EE;'>#统计#</a>限制性立方样条回归分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78931, encryptionId=84a7e893169, topicName=统计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jun 27 09:21:14 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977173, encodeId=5a089e717352, content=<a href='/topic/show?id=9b3996e6940' target=_blank style='color:#2F92EE;'>#锰#</a><a href='/topic/show?id=001450815b3' target=_blank style='color:#2F92EE;'>#微量元素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96769, encryptionId=9b3996e6940, topicName=锰), TopicDto(id=50815, encryptionId=001450815b3, topicName=微量元素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Jun 26 23:37:15 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-06-27 小小医者

    这个研究亮点采用了#统计#限制性立方样条回归分析

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1878385, encodeId=312d18e838557, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Feb 10 08:48:09 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861444, encodeId=8ba81861444b3, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Sep 21 16:48:09 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729002, encodeId=5e111e2900237, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Dec 17 15:48:09 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524322, encodeId=d4251524322d7, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621905, encodeId=82c21621905f7, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Jun 28 13:48:09 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977222, encodeId=e9c49e722259, content=这个研究亮点采用了<a href='/topic/show?id=84a7e893169' target=_blank style='color:#2F92EE;'>#统计#</a>限制性立方样条回归分析, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78931, encryptionId=84a7e893169, topicName=统计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jun 27 09:21:14 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977173, encodeId=5a089e717352, content=<a href='/topic/show?id=9b3996e6940' target=_blank style='color:#2F92EE;'>#锰#</a><a href='/topic/show?id=001450815b3' target=_blank style='color:#2F92EE;'>#微量元素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96769, encryptionId=9b3996e6940, topicName=锰), TopicDto(id=50815, encryptionId=001450815b3, topicName=微量元素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Jun 26 23:37:15 CST 2021, time=2021-06-26, status=1, ipAttribution=)]

相关资讯

Neurology:血压变异越大,认知减退越快

血压变异越大,认知减退越快

梅斯心血管疾病进展(004期)

编者按:梅斯医学将定期进行汇总,帮助大家概览心血管领域最新进展。下面是呈现给大家的最新一期的心血管进展。enjoy~

JACC:肾去神经支配术可显著降低高血压患者的血浆肾素活性

肾去神经支配术治疗可明显降低高血压患者的血浆肾素活性和醛固酮水平

Alzheimers Dementia: 收缩压变异越大,痴呆风险越高

收缩压变异越大,痴呆风险越高

已经吃了降压药, 为什么血压还是降不下来?找找原因!

我已经吃了降压药,为什么血压还是降不下来?刚刚血压降下来,怎么又回去了?

拓展阅读

Eur J Epidemiol:每天吃5-6克洋葱,可以降低肝癌风险33%

结果表明,较高的视黄醇摄入量与肝癌风险增加相关,而较高的洋葱和锰摄入量与肝癌风险降低相关。

Biomaterials:中国海洋大学赵峡教授团队发现基于细胞焦亡和STING通路新型复合纳米粒抗癌有点“锰”

近期,中国海洋大学赵峡教授课题组结合基于透明质酸(HA)紫杉醇(PTX)前药与免疫系统的“传令兵”锰离子(Mn2+),设计了一种新型复合纳米粒(Mn-HSP)。

微量元素——锰与免疫健康

锰是一种人体14种必需的微量元素,在人体内的含量仅次于铁。锰具有提高免疫力、维持神经、改善造血系统、维持心脏和肌肉功能、预防心脑血管疾病等作用与功效。茶叶、小麦以及硬壳果实含锰较多。

NEJM:一例10 年进行性书写障碍和言语快速、含糊不清病例

一名 55 岁男性因有 10 年进行性书写障碍和言语快速、含糊不清的病史就诊于神经科诊所。

Radiology:锰与钆的对决--谁才是MR对比剂王座的主人?

本研究旨在比较锰磁共振(MR)对比剂Mn-PyC3A与钆MR对比剂Gd-DTPA的血管内强化效果,评价Mn-PyC3A的排泄、药物动力学参数和代谢,并将结果发表在Radiology上。

Neurology:在锰暴露的焊工中帕金森疾病进展呈剂量依赖性

暴露于含锰的焊接烟尘可引起剂量依赖性的帕金森疾病进展,尤其是上肢运动迟缓、肢体僵硬及语音和面部表情功能受损